Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.18% | 24.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.18% | 24.61% | |||
| Cost of Revenue | 1.39% | 24.27% | |||
| Gross Profit | 4.05% | 24.78% | |||
| SG&A Expenses | 3.33% | 25.02% | |||
| Depreciation & Amortization | -1.15% | 4.82% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.86% | 23.27% | |||
| Operating Income | 9.48% | 31.45% | |||
| Income Before Tax | -23.48% | 81.52% | |||
| Income Tax Expenses | 270.57% | -152.02% | |||
| Earnings from Continuing Operations | -41.35% | 168.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.35% | 168.81% | |||
| EBIT | 9.48% | 31.45% | |||
| EBITDA | 6.39% | 21.56% | |||
| EPS Basic | -41.05% | 171.89% | |||
| Normalized Basic EPS | 10.96% | 26.49% | |||
| EPS Diluted | -40.94% | 175.93% | |||
| Normalized Diluted EPS | 11.30% | 28.03% | |||
| Average Basic Shares Outstanding | -0.52% | -1.13% | |||
| Average Diluted Shares Outstanding | -0.81% | -2.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||